Covaxin Approved In Nepal For Emergency Use

Covaxin Approved In Nepal For Emergency Use

March 20, 2021, 7:57 a.m.

Nepal Approves Covaxin For Emergency Use In Nepal. According to the Department of Drug Administration (DDA), it has given approval to 'Covaxin', a vaccine against novel coronavirus, for emergency use in Nepal.

The DDA gave approval to Covaxin on Friday on the recommendation of the Drug Advisory Committee. Following this, Nepal is the third country to approve it.

Covaxin is being produced by an Indian company called Bharat Biotech International Limited.

Bharat Bhattarai, Director General at the DDA the number of companies receiving Nepal's approval for use has reached three. Prior to this, Covishield and Sinopharm had received the government's nod for emergency use.

Bhattarai said that two more companies producing COVID-19 vaccines had filed applications at the department for approval. "Russia's Sputnik V and China's Sinovac have applied to receive approval for use," he said.

More on Health

The Latest

Latest Magazine

VOL. 15, No. 01, July 16, 2021 (Shrawan 1, 2078) Publisher and Editor: Keshab Prasad Poudel Online Register Number: DOI 584/074-75

VOL. 14, No. 20, July 2, 2021 (Asadh 18, 2078) Publisher and Editor: Keshab Prasad Poudel Online Register Number: DOI 584/074-75

VOL. 14, No. 19, June 18, 2021 (Asadh 4, 2078) Publisher: Keshab Prasad Poudel Online Register Number: DOI 584/074-75

VOL. 14, No. 18, June 04, 2021 (Jestha 21, 2078) Publisher: Keshab Prasad Poudel Online Register Number: DOI 584/074-75